Arcturus Therapeutics, Inc. — Form D
Arcturus Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2013-12-18. The offering totals $14.0M, of which $4.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-12-18
- Form: D
- Accession: 0001573745-13-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $14.0M
- Amount sold: $4.6M
- Remaining: $9.4M
- Minimum investment: $10K
- Investors: 18
- Date of first sale: 2013-09-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-208184
Issuer
- Name: Arcturus Therapeutics, Inc.
- CIK: 0001573745
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 10628 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, CA, 92121
- Phone: (858) 900-2660
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Craig Edward Willett | Director | San Diego, CA |
| Joseph Edward Payne | Director | San Diego, CA |
| Joseph Edward Payne | Executive Officer | San Diego, CA |
| Padmanabh Edward Chivukula | Director | San Diego, CA |
| Padmanabh Edward Chivukula | Executive Officer | San Diego, CA |
Other filings by this issuer (3)
More